Assay can ID M. tuberculosis resistance mutations

September 15, 2017

(HealthDay)—An automated molecular assay can detect Mycobacterium tuberculosis with resistance to drugs directly from sputum specimens, according to a study published in the Sept. 14 issue of the New England Journal of Medicine.

Yingda L. Xie, M.D., from the National Institutes of Health in Bethesda, Md., and colleagues compared the investigational assay against phenotypic drug-susceptibility testing and DNA sequencing among adults with symptoms of tuberculosis. The authors performed the Xpert MTB/RIF assay and sputum culture.

The researchers found that the sensitivities of the investigational assay for detecting resistance were 83.3 percent for isoniazid, 88.4 percent for ofloxacin, 87.6 percent for moxifloxacin, 71.4 percent for kanamycin, and 70.7 percent for amikacin among the 308 participants who were culture-positive for M. tuberculosis when phenotypic drug-susceptibility testing was used as the reference standard. For detection of phenotypic resistance the specificity of the assay was 93.4 percent or greater for all drugs except moxifloxacin at a critical concentration of 2.0 µg/mL. Using DNA sequencing as the reference standard, the sensitivities of the investigational assay for detecting mutations associated with resistance were 98.1, 95.8, 92.7, and 96.8 for isoniazid, fluoroquinolones, kanamycin, and amikacin; the specificity for all drugs was 99.6 percent or greater.

"This investigational assay accurately detected M. tuberculosis mutations associated with to isoniazid, fluoroquinolones, and aminoglycosides and holds promise as a rapid point-of-care test to guide therapeutic decisions for patients with tuberculosis," the authors write.

Explore further: New diagnostics tool, the Xpert Ultra assay, improves detection of mycobacterium tuberculosis

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New diagnostics tool, the Xpert Ultra assay, improves detection of mycobacterium tuberculosis

August 29, 2017
Researchers have demonstrated a new, improved version of the Xpert MTB/RIF assay, a test for Rifampicin-resistance (RIF-R). The Xpert "Ultra" assay overcomes the shortcomings of the current Xpert assay to significantly improve ...

Improving detection of drug-resistant tuberculosis

May 2, 2012
(Medical Xpress) -- European researchers are developing new assays to detect drug resistant strains of Mycobacterium tuberculosis.

Tuberculosis drug may work better than others in its class

August 17, 2017
Treatment of tuberculosis involves a combination of several drugs, sometimes including drugs from a class known as fluoroquinolones. Using computer simulations, scientists have shown that the fluoroquinolone known as moxifloxacin ...

TB: Genetic drug resistance tests as good in gauging treatment outcome, death risk as traditional culture-based tests

August 3, 2017
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death ...

Rapid testing for TB aims to reduce drug resistance, lower mortality rate

September 3, 2015
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive ...

Rapid diagnostic tests decrease waiting time for drug-resistant TB patients

September 8, 2013
Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method.

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.